Pretreatment and Treatment With L -Arginine Attenuate Weight Loss and Bacterial Translocation in Dextran Sulfate Sodium Colitis

Abstract

Background: Imbalances in a variety of factors, including genetics, intestinal flora, and mucosal immunity, can contribute to the development of ulcerative colitis and its side effects. This study evaluated the effects of pretreatment or treatment with arginine by oral administration on intestinal permeability, bacterial translocation (BT), and mucosal intestinal damage due to colitis. Methods: C57BL/6 mice were distributed into 4 groups: standard diet and water (C: control group), standard diet and dextran sodium sulfate (DSS) solution (Col: colitis group), 2% L-arginine supplementation for 7 days prior to DSS administration and during disease induction (PT: pretreated group), and 2% L-arginine supplementation during disease induction (T: treated group). Colitis was induced by administration of 1.5% DSS for 7 days. After 14 days, intestinal permeability and BT were evaluated; colons were collected for histologic analysis and determination of cytokines; feces were collected for measurement of immunoglobulin A (IgA). Results: The Col group showed increased intestinal permeability (C vs Col: P < .05) and BT (C vs Col: P < .05). In the arginine-supplemented groups (PT and T), this amino acid tended to decrease intestinal permeability. Arginine decreased BT to liver during PT (P < .05) and to blood, liver, spleen, and lung during T (P < .05). Histologic analysis showed that arginine preserved the intestinal mucosa and tended to decreased inflammation. Conclusions: Arginine attenuates weight loss and BT in mice with colitis.

Keywords

arginine inflammatory bowel diseases colitis bacterial translocation intestinal mucosa

Get full access to this article

View all access options for this article.

References

Kugathasan

Fiocchi

. Progress in basic inflammatory bowel disease research. Semin Pediatr Surg. 2007;16:146-153.

Scaldaferri

Fiocchi

. Inflammatory bowel disease: progress and current concepts of etiopathogenesis. J Dig Dis. 2007;8:171-178.

Braus

Elliott

. FOCIS on FOCiS: Advances in the pathogenesis and treatment of IBD. Clin Immunol. 2009;132:1-9.

Pomar

MDB

Casariego

Fernández

Gómez

JJL

Fondo

Rodríguez

. Impacto de la nutrición en la evolución de la enfermedad inflamatória intestinal. Nutr Hosp. 2010;25:181-192.

Uhlig

Powrie

. Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease. Eur J Immunol. 2009;39:2021-2026.

Coburn

Gong

Singh

. L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis. PLoS ONE. 2012;7:2012.

Morris

. Arginine metabolism: nitric oxide and beyond. Biochem J. 1998;336:1-17.

Choi

Martinez-Falero

Corset

. Differential impact of L-arginine deprivation on the activation and effector functions of T cells and macrophages. J Leukoc Biol. 2009;85:268-277.

Bazer

Davis

. Arginine metabolism and nutrition in growth, health and disease. Amino Acids. 2009;37:153-168.

10.

Ren

Yin

. Serum amino acids profile and the beneficial effects of L-arginine or L-glutamine supplementation in dextran sulfate sodium colitis. PLoS ONE. 2014;9:e88335.

11.

Quirino

IEP

Correia

MITD

Cardoso

. The impact of arginine on bacterial translocation in an intestinal obstruction model in rats. Clin Nutr. 2007;26:335-340.

12.

Viana

Santos

RGC

Generoso

Arantes

RME

Correia

MITD

Cardoso

. Pretreatment with arginine preserves intestinal barrier integrity and reduces bacterial translocation in mice. Nutrition. 2010;26:218-223.

13.

Quirino

IEP

Cardoso

Santos

RGC

. The role of L-arginine and inducible nitric oxide synthase in intestinal permeability and bacterial translocation. JPEN J Parenter Enteral Nutr. 2013;37:392-400.

14.

Viana

Santos

RGC

Generoso

. The role of L-arginine-nitric oxide pathway in bacterial translocation. Amino Acids. 2013;45:1089-1096.

15.

Costa

Soares

ADN

Wanner

. L-arginine supplementation prevents increases in intestinal permeability and bacterial translocation in male Swiss mice subjected to physical exercise under environmental heat stress. J Nutr. 2014;144:218-223.

16.

Reeves

Nielsen

Fahey

. AIN-93. Purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939-1951.

17.

Wirtz

Neufert

Weigmann

Neurath

. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2:541-546.

18.

Jorgensen

Nielsen

Espersen

Perner

. Increased colorectal permeability in patients with severe sepsis and septic shock. Intensive Care Med. 2006;32:1790-1796.

19.

Diniz

SOF

Resende

Nunan

Simal

CJR

Cardoso

. 99mTechnetium labelled Escherichia coli. Appl Radiat Isot. 1999;51:33-36.

20.

Solomon

Mansor

Mallon

. The dextran sulphate sodium (DSS) model of colitis: an overview. Comp Clin Pathol. 2010;19:235-239.

21.

Perše

Cerar

. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol. 2012;2012:1-13.

22.

Feng

Wang

Schoeb

Elson

Cong

. Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis. J Exp Med. 2010;207:1321-1332.

23.

Leonel

Teixeira

Oliveira

. Antioxidative and immunomodulatory effects of tributyrin supplementation on experimental colitis. Br J Nutr. 2013;109:1396-1407.

24.

Ban

Shigemitsu

Yamatsuji

. Arginine and leucine regulate p70 S6 kinase and 4E-BP1 in intestinal epithelial cells. Int J Mol Med. 2004;13:537-543.

25.

Rhoads

Niu

Odle

Graves

. Role of mTOR signaling in intestinal cell migration. Am J Physiol Gastrointest Liver Physiol. 2006;291:G510-G517.

26.

Corl

Odle

Niu

. Arginine activates intestinal p70(S6k) and protein synthesis in piglet rotavirus enteritis. J Nutr. 2008;138:24-29.

27.

McCormack

Johnson

. Role of polyamines in gastrointestinal mucosal growth. Am J Physiol. 1991;260:G795-806.

28.

Puiman

Stoll

Goudoever

Burrin

. Enteral arginine does not increase superior mesenteric arterial blood flow but induces mucosal growth in neonatal pigs. J Nutr. 2011;141:63-70.

29.

Larqué

Molina-Sabater

Zamora

. Biological significance of dietary polyamines. Nutrition. 2007;23:87-95.

30.

Peyrin-Biroulet

Gonzalez

Dubuquoy

. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn’s disease. Gut. 2012;61:78-85.

31.

Tanaka

Mizoguchi

Kunikata

Miyazawa

Takeuchi

. Protection by constitutively formed nitric oxide of intestinal damage induced by indomethacin in rats. J Physiol Paris. 2001;95:35-41.

32.

Wiest

Ratch

. Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol. 2003;17:397-425.

33.

Peterson

Artis

. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev. 2014;14:141-153.

34.

Chapman

Liu

Zhu

Rhoads

. Arginine and citrulline protect intestinal cell monolayer tight junctions from hypoxia-induced injury in piglets. Pediatr Res. 2012;72:576-582.

35.

Mañe

Fernández-Bañares

Ojanguren

. Effect of L-arginine on the course of experimental colitis. Clin Nutr. 2001;20:415-422.

36.

Kozar

Verner-Cole

Schultz

. The immune-enhancing enteral agents arginine and glutamine differentially modulate gut barrier function following mesenteric ischemia/reperfusion. J Trauma. 2004;57:1150-1156.

37.

Sato

Moore

Kone

. Differential induction of PPAR-γ by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel. Am J Physiol Gastrointest Liver Physiol. 2006;290:G616-G623.

38.

Robinson

Kelly

Mercer

Kozar

. Differential effects of luminal arginine and glutamine on metalloproteinase production in the postischemic gut. JPEN J Parenter Enteral Nutr. 2008;32:433-438.

39.

Ban

Santora

Kozar

. Enteral arginine modulates inhibition of AP-1/c-Jun by SP600125 in the postischemic gut. Mol Cell Biochem. 2011;347:191-199.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.28 MB